Electronic Consent: Website Guidance & Memo for Sponsors

The UCSF Human Research Protection Program and Office of Research leadership have developed guidance on using DocuSign and REDCap to obtain electronic signatures for research consent and HIPAA authorization during the COVID-19 public health emergency.

The following resources are now available on the IRB COVID-19 FAQs & Resources website:

1. Detailed guidance about obtaining electronic consent signatures: See FAQ #2 and the FDA Resources list.

2. Memo that researchers can share with sponsors about the use of DocuSign and REDCap for obtaining electronic signatures: Attached to this email, and also available at Sponsor Memos.